⚠ COVID-19 INFORMATION: Vaccine Information, Other Resources 

A Study to Evaluate EDP 938 Regimens in Infants With RSV (RSVPEDs)

Official Title: A Study to Evaluate EDP 938 Regimens in Infants With RSV (RSVPEDs)

This is a randomized, double-blind, dose ranging, placebo-controlled study in respiratory syncytial virus (RSV) among hospitalized and non-hospitalized children aged from 28 days to 24 months, assessing the safety, tolerability, pharmacokinetics, clinical outcome and antiviral activity of a 5 day treatment with EDP-938.

NCT04816721
Muller, William J., MD, PhD
Interventional
Yes

Contact Information:

Laura Fearn

312.227.6285